Skip to search.
 FTSE 100 Down 0.33%

Alkermes plc (ALKS)

-NasdaqGS Ticker: 56GVS1/ISIN: IE00B56GVS15
56.25 Up 1.36(2.48%) 2 Dec 21:00
Prev Close:54.89
Open:54.87
Bid:36.69 x 100
Ask:65.00 x 100
1y Target Est:65.27
Beta:2.02162
Earnings Date:23 Feb - 27 Feb (Est.)
Day's Range:54.37 - 56.73
52wk Range:27.14 - 80.71
Volume:892,820
Avg Vol (3m):1,222,240
Market Cap:8.55b
P/E (ttm):N/A
EPS (ttm):-1.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSUp 2.48%8.55b
LLYUp 2.64%71.45b
GSKUp 0.72%93.89b
ABTUp 0.80%55.80b

Key Statistics

Forward P/E (1 yr):175.78
P/S (ttm):12.00
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.20
Quarterly EPS Est (Dec-16) :0.04
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):9.90

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products that are designed to address unmet medical needs of patients in various therapeutic areas worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback